Weeden, Clare E <br/><br/>
Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma.  [electronic resource] 

 -  Molecular cancer therapeutics  08 2017 
 - 1610-1622 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-17-0174  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Differentiation--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cisplatin--pharmacology<br/>Genotype<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mice, Inbred NOD<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>RNA, Messenger--genetics<br/>Receptor, Fibroblast Growth Factor, Type 1--antagonists & inhibitors<br/>Survival Analysis<br/>Xenograft Model Antitumor Assays